Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

Glucagon-like peptide-2 (GLP-2) is a recently characterized intestine-derived peptide that exerts trophic activity in the small and large intestine. Whether circulating levels of GLP-2 are perturbed in the setting of human inflammatory bowel disease (IBD) remains unknown.

Saved in:
Bibliographic Details
Published in:American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2000-04, Vol.47 (4), p.R1057-R1063
Main Authors: QIANG XIAO, BOUSHEY, R. P, CINO, M, DRUCKER, D. J, BRUBAKER, P. L
Format: Article
Language:English
Subjects:
Biological and medical sciences
Cellular biology
Disease
Excretory system
Gastroenterology. Liver. Pancreas. Abdomen
Medical sciences
Other diseases. Semiology
Peptides
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glucagon-like peptide-2 (GLP-2) is a recently characterized intestine-derived peptide that exerts trophic activity in the small and large intestine. Whether circulating levels of GLP-2 are perturbed in the setting of human inflammatory bowel disease (IBD) remains unknown.
ISSN:0363-6119
1522-1490